Tissue Acquisition for Molecular Diagnostics
N/A
N/A
Both
Neoplasm
Trial Information
Tissue Acquisition for Molecular Diagnostics
Acquisition of fresh tumor and normal tissue samples is necessary for the preparation of
cDNA libraries, microarray chips, tissue specific probes, and proteomics development and
validation. This protocol will allow acquisition of patient samples at the time of tissue
sampling for surgery, diagnostic tests, or therapeutic phereses. These samples will be
forwarded without patient identifiers, pathology reports, or other labels. Tissue pathology
will be verified within the Laboratory of Pathology and samples used strictly for CGAP and
Proteomic Initiative indications.
Inclusion Criteria
INCLUSION CRITERIA:
All patients willing to sign the informed consent for whom tissue, blood or body fluids
will be available are eligible.
Histopathologic diagnosis will be confirmed in the Laboratory of Pathology, National
Cancer Institute and is not a criteria for inclusion.
Type of Study:
Observational
Study Design:
N/A
Authority:
United States: Federal Government
Study ID:
970138
NCT ID:
NCT00001580
Start Date:
June 1997
Completion Date:
March 2003
Related Keywords:
- Neoplasm
- Molecular Diagnostics
- Ovary
- Tissue Acquisition
- cDNA Library
- CGAP
- Neoplasms
Name | Location |
|---|---|
| National Cancer Institute (NCI) | Bethesda, Maryland 20892 |
